Beam Therapeutics Inc (BEAM) — Free Cash Flow Generation Index
Beam Therapeutics Inc (BEAM) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $131.48 Million represents 1% of operating cash flow ($135.07 Million). Read Beam Therapeutics Inc (BEAM) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beam Therapeutics Inc Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for Beam Therapeutics Inc across 1 annual periods. Explore reinvestment intensity of Beam Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Beam Therapeutics Inc (2022–2022)
Year-by-year Free Cash Flow Generation Index for Beam Therapeutics Inc. For the full company profile including market capitalisation, see BEAM market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.17x | $-26.42 Million | $22.53 Million | $48.95 Million | — |